Abstract:Background/Aims . Diabetic kidney disease (DKD) is a leading cause of end-stage renal disease. Calcium dobesilate (CaD) is widely used to treat diabetic retinopathy. Recent studies have demonstrated that CaD exerts protective effects against diabetic nephropathy. The aim of this study was to elucidate the molecular and cellular mechanisms underlying the protective effects of CaD. Methods . Human umbilical vein endothelial cells (HUVECs) were cultured with different D-glucose concentrations to determine the effects of high glucose on HUVEC gene expression. HUVECs were also incubated with CaD (25 μ M, 50 μ M, and 100 μ M) for 3 days to determine the effects of CaD on HUVEC viability. db/db mice were treated with CaD. 2-[(Aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide (TPCA-1) blocked the nuclear factor- κ B (NF- κ B) pathway in HUVECs. A pentraxin 3 (PTX3) small interfering RNA (siRNA) intervention experiment was performed in the cells. An adenovirus-encapsulated PTX3 siRNA intervention experiment was performed in db/db mice. Western blot and real-time PCR analyses were used to detect PTX3, p-IKBa/IKBa (I-kappa-B-alpha), and p-eNOS/eNOS (endothelial nitric oxide synthase) expression in mice and HUVECs. Hematoxylin-eosin (HE) staining and periodic acid-Schiff (PAS) staining were used to observe renal tissue damage in mice. PTX3 expression was observed by immunohistochemical staining. Results . CaD downregulated the expression of PTX3 and p-IKBa/IKBa and upregulated the expression of p-eNOS/eNOS in vitro. When TPCA-1 was used, high glucose induced high PTX3 expression, and the expression of p-eNOS/eNOS increased. After PTX3 gene silencing, the expression of p-eNOS/eNOS also increased. In vivo, CaD reduced the expression of PTX3 and p-IKBa/IKBa in the kidneys of db/db mice and increased the expression of p-eNOS/eNOS. After PTX3 gene silencing, the urine protein and renal function of db/db mice were ameliorated, the glomerular extracellular matrix was decreased, and the expression of p-eNOS/eNOS was increased. Conclusions . Our results suggested that CaD may inhibit the expression of PTX3 by altering the IKK/IKB/NF- κ B pathway, thereby improving endothelial dysfunction in HUVECs. PTX3 may be a potential therapeutic target for DKD.

CKIP-1 participates in the activation of Nrf2 signaling pathway by Cx43 and the regulation of diabetic renal fibrosis

CKIP-1 acts downstream to Cx43 on the activation of Nrf2 signaling pathway to protect from renal fibrosis in diabetes

Connexin 43 Prevents the Progression of Diabetic Renal Tubulointerstitial Fibrosis by Regulating the SIRT1-HIF-1α Signaling Pathway

CKIP-1 Affects the Polyubiquitination of Nrf2 and Keap1 Via Mediating Smurf1 to Resist HG-induced Renal Fibrosis in GMCs and Diabetic Mice Kidneys.

CKIP-1 Ameliorates High Glucose-Induced Expression of Fibronectin and Intercellular Cell Adhesion Molecule-1 by Activating the Nrf2/ARE Pathway in Glomerular Mesangial Cells

The Ubiquitination of CKIP-1 Mediated by Src Aggravates Diabetic Renal Fibrosis (original Article)

Connexin43 regulates high glucose-induced expression of fibronectin, ICAM-1 and TGF-β1 via Nrf2/ARE pathway in glomerular mesangial cells.

Connexin32 Ameliorates Epithelial-to-Mesenchymal-Transition in Diabetic Renal Tubular Via Inhibiting NOX4

Protein Kinase CK2α Catalytic Subunit Ameliorates Diabetic Renal Inflammatory Fibrosis Via NF-κB Signaling Pathway.

Polydatin Promotes Nrf2-ARE Anti-Oxidative Pathway Through Activating CKIP-1 to Resist HG-induced Up-Regulation of FN and ICAM-1 in GMCs and Diabetic Mice Kidneys.

Connexin43 Mediates Nf-Kappa B Signalling Activation Induced By High Glucose In Gmcs: Involvement Of C-Src

Connexin43 mediates NF-κB signalling activation induced by high glucose in GMCs: involvement of c-Src

Investigation of the Mechanism Underlying Calcium Dobesilate-Mediated Improvement of Endothelial Dysfunction and Inflammation Caused by High Glucose

Connexin32 Ameliorates Renal Fibrosis in Diabetic Mice by Promoting K48-linked NADPH Oxidase 4 Polyubiquitination and Degradation

Connexin32 Promotes the Activation of Foxo3a to Ameliorate Diabetic Nephropathy Via Inhibiting the Polyubiquitination and Degradation of Sirt1

Effects of HIF-1α on renal fibrosis in cisplatin-induced chronic kidney disease

Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice

Fraxin Promotes the Activation of Nrf2/ARE Pathway via Increasing the Expression of Connexin43 to Ameliorate Diabetic Renal Fibrosis

Targeting the CDA1/CDA1BP1 Axis Retards Renal Fibrosis in Experimental Diabetic Nephropathy.

CK2α Promotes Advanced Glycation End Products-Induced Expressions of Fibronectin and Intercellular Adhesion Molecule-1 Via Activating MRTF-A in Glomerular Mesangial Cells.

Effects of the S1P/S1PR1 Signaling Pathway on High Glucose-Induced NRK-52E Epithelial-Mesenchymal Transition Via Regulation of ROS/NLRP3